Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended
Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Due to related party	$ 916,270		$ 730,629
Warrants issued for remaining debt amount	739,772
Autotelic [Member]
Billed expenses	256,997	$ 213,103
Personnel cost	$ 133,633	$ 158,140
Master Services Agreement [Member]
Ownership interest	5.00%
Proceeds from common or preferred stock, gross	$ 10,000,000
Compensation description	After the Equity Financing Date, the Company shall pay Autotelic a cash amount equal to the actual labor cost plus 100% mark up of provided services and 20% mark up of provided services by third party contractors or material used in connection with the performance of the contracts, including but not limited to clinical trial, non-clinical trial, Contract Manufacturing Organizations (“CMO”), U.S. Food & Drug Administration (“FDA”) regulatory process, Contract Research Organizations (“CRO”) and Chemistry and Manufacturing Controls (“CMC”).
Master Services Agreement [Member] \| Related Party [Member]
Service provider percentage	20.00%

$ 916,270

$ 730,629

$ 133,633

$ 158,140

5.00%

After the Equity Financing Date, the Company shall pay Autotelic a cash amount equal to the actual labor cost plus 100% mark up of provided services and 20% mark up of provided services by third party contractors or material used in connection with the performance of the contracts, including but not limited to clinical trial, non-clinical trial, Contract Manufacturing Organizations (“CMO”), U.S. Food & Drug Administration (“FDA”) regulatory process, Contract Research Organizations (“CRO”) and Chemistry and Manufacturing Controls (“CMC”).

Service provider percentage

20.00%